nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP3A7-CYP3A51P—Hydrocortisone—rheumatoid arthritis	0.0421	0.0637	CbGbCtD
Nefazodone—CYP3A7—Hydrocortisone—rheumatoid arthritis	0.0421	0.0637	CbGbCtD
Nefazodone—CYP3A7—Cyclosporine—rheumatoid arthritis	0.0398	0.0602	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Cyclosporine—rheumatoid arthritis	0.0398	0.0602	CbGbCtD
Nefazodone—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.0394	0.0596	CbGbCtD
Nefazodone—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0338	0.0511	CbGbCtD
Nefazodone—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.0316	0.0478	CbGbCtD
Nefazodone—CYP3A5—Cyclosporine—rheumatoid arthritis	0.0298	0.0451	CbGbCtD
Nefazodone—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0275	0.0416	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Dexamethasone—rheumatoid arthritis	0.0262	0.0396	CbGbCtD
Nefazodone—CYP3A7—Dexamethasone—rheumatoid arthritis	0.0262	0.0396	CbGbCtD
Nefazodone—ABCB1—Betamethasone—rheumatoid arthritis	0.022	0.0333	CbGbCtD
Nefazodone—ABCB1—Prednisolone—rheumatoid arthritis	0.0217	0.0328	CbGbCtD
Nefazodone—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0206	0.0311	CbGbCtD
Nefazodone—ABCB1—Prednisone—rheumatoid arthritis	0.0205	0.031	CbGbCtD
Nefazodone—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0203	0.0306	CbGbCtD
Nefazodone—CYP3A5—Dexamethasone—rheumatoid arthritis	0.0197	0.0297	CbGbCtD
Nefazodone—ABCB1—Cyclosporine—rheumatoid arthritis	0.0194	0.0294	CbGbCtD
Nefazodone—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0183	0.0277	CbGbCtD
Nefazodone—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0154	0.0232	CbGbCtD
Nefazodone—CYP3A4—Betamethasone—rheumatoid arthritis	0.0132	0.0199	CbGbCtD
Nefazodone—CYP3A4—Prednisolone—rheumatoid arthritis	0.013	0.0197	CbGbCtD
Nefazodone—ABCB1—Dexamethasone—rheumatoid arthritis	0.0128	0.0193	CbGbCtD
Nefazodone—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0123	0.0186	CbGbCtD
Nefazodone—CYP3A4—Prednisone—rheumatoid arthritis	0.0123	0.0186	CbGbCtD
Nefazodone—CYP2D6—Dexamethasone—rheumatoid arthritis	0.0121	0.0182	CbGbCtD
Nefazodone—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0116	0.0176	CbGbCtD
Nefazodone—ABCB1—Methotrexate—rheumatoid arthritis	0.0103	0.0155	CbGbCtD
Nefazodone—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00766	0.0116	CbGbCtD
Nefazodone—Nausea—Azathioprine—rheumatoid arthritis	0.000155	0.000543	CcSEcCtD
Nefazodone—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000155	0.000543	CcSEcCtD
Nefazodone—Headache—Leflunomide—rheumatoid arthritis	0.000154	0.000541	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000154	0.00054	CcSEcCtD
Nefazodone—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000154	0.000539	CcSEcCtD
Nefazodone—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000153	0.000538	CcSEcCtD
Nefazodone—Convulsion—Dexamethasone—rheumatoid arthritis	0.000153	0.000537	CcSEcCtD
Nefazodone—Convulsion—Betamethasone—rheumatoid arthritis	0.000153	0.000537	CcSEcCtD
Nefazodone—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000153	0.000536	CcSEcCtD
Nefazodone—Hypertension—Dexamethasone—rheumatoid arthritis	0.000153	0.000535	CcSEcCtD
Nefazodone—Hypertension—Betamethasone—rheumatoid arthritis	0.000153	0.000535	CcSEcCtD
Nefazodone—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000152	0.000532	CcSEcCtD
Nefazodone—Urticaria—Cyclosporine—rheumatoid arthritis	0.000151	0.00053	CcSEcCtD
Nefazodone—Myalgia—Dexamethasone—rheumatoid arthritis	0.000151	0.000528	CcSEcCtD
Nefazodone—Myalgia—Betamethasone—rheumatoid arthritis	0.000151	0.000528	CcSEcCtD
Nefazodone—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.00015	0.000527	CcSEcCtD
Nefazodone—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.00015	0.000527	CcSEcCtD
Nefazodone—Anxiety—Betamethasone—rheumatoid arthritis	0.00015	0.000526	CcSEcCtD
Nefazodone—Anxiety—Dexamethasone—rheumatoid arthritis	0.00015	0.000526	CcSEcCtD
Nefazodone—Discomfort—Dexamethasone—rheumatoid arthritis	0.000149	0.000522	CcSEcCtD
Nefazodone—Discomfort—Betamethasone—rheumatoid arthritis	0.000149	0.000522	CcSEcCtD
Nefazodone—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000149	0.000521	CcSEcCtD
Nefazodone—Haemoglobin—Methotrexate—rheumatoid arthritis	0.000149	0.000521	CcSEcCtD
Nefazodone—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000148	0.00052	CcSEcCtD
Nefazodone—Pain—Prednisolone—rheumatoid arthritis	0.000148	0.000519	CcSEcCtD
Nefazodone—Haemorrhage—Methotrexate—rheumatoid arthritis	0.000148	0.000518	CcSEcCtD
Nefazodone—Hepatitis—Methotrexate—rheumatoid arthritis	0.000148	0.000518	CcSEcCtD
Nefazodone—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000147	0.000515	CcSEcCtD
Nefazodone—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000147	0.000515	CcSEcCtD
Nefazodone—Nausea—Leflunomide—rheumatoid arthritis	0.000146	0.000513	CcSEcCtD
Nefazodone—Vision blurred—Prednisone—rheumatoid arthritis	0.000145	0.000509	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000145	0.000508	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000145	0.000507	CcSEcCtD
Nefazodone—Pain—Hydrocortisone—rheumatoid arthritis	0.000144	0.000507	CcSEcCtD
Nefazodone—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000144	0.000506	CcSEcCtD
Nefazodone—Oedema—Betamethasone—rheumatoid arthritis	0.000144	0.000506	CcSEcCtD
Nefazodone—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000144	0.000506	CcSEcCtD
Nefazodone—Oedema—Dexamethasone—rheumatoid arthritis	0.000144	0.000506	CcSEcCtD
Nefazodone—Insomnia—Triamcinolone—rheumatoid arthritis	0.000144	0.000504	CcSEcCtD
Nefazodone—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000144	0.000503	CcSEcCtD
Nefazodone—Infection—Dexamethasone—rheumatoid arthritis	0.000143	0.000503	CcSEcCtD
Nefazodone—Infection—Betamethasone—rheumatoid arthritis	0.000143	0.000503	CcSEcCtD
Nefazodone—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000143	0.000501	CcSEcCtD
Nefazodone—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000143	0.000501	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000143	0.0005	CcSEcCtD
Nefazodone—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000143	0.0005	CcSEcCtD
Nefazodone—Visual impairment—Methotrexate—rheumatoid arthritis	0.000143	0.0005	CcSEcCtD
Nefazodone—Anaemia—Prednisone—rheumatoid arthritis	0.000142	0.000499	CcSEcCtD
Nefazodone—Shock—Betamethasone—rheumatoid arthritis	0.000142	0.000498	CcSEcCtD
Nefazodone—Shock—Dexamethasone—rheumatoid arthritis	0.000142	0.000498	CcSEcCtD
Nefazodone—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000142	0.000497	CcSEcCtD
Nefazodone—Agitation—Prednisone—rheumatoid arthritis	0.000142	0.000496	CcSEcCtD
Nefazodone—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000141	0.000496	CcSEcCtD
Nefazodone—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000141	0.000496	CcSEcCtD
Nefazodone—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000141	0.000494	CcSEcCtD
Nefazodone—Tachycardia—Betamethasone—rheumatoid arthritis	0.000141	0.000494	CcSEcCtD
Nefazodone—Angioedema—Prednisone—rheumatoid arthritis	0.000141	0.000493	CcSEcCtD
Nefazodone—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.00014	0.000491	CcSEcCtD
Nefazodone—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.00014	0.000491	CcSEcCtD
Nefazodone—Erythema multiforme—Methotrexate—rheumatoid arthritis	0.00014	0.00049	CcSEcCtD
Nefazodone—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.00014	0.00049	CcSEcCtD
Nefazodone—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.00014	0.000489	CcSEcCtD
Nefazodone—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.00014	0.000489	CcSEcCtD
Nefazodone—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000139	0.000488	CcSEcCtD
Nefazodone—Malaise—Prednisone—rheumatoid arthritis	0.000139	0.000487	CcSEcCtD
Nefazodone—Vertigo—Prednisone—rheumatoid arthritis	0.000138	0.000485	CcSEcCtD
Nefazodone—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000138	0.000484	CcSEcCtD
Nefazodone—Syncope—Prednisone—rheumatoid arthritis	0.000138	0.000484	CcSEcCtD
Nefazodone—Tinnitus—Methotrexate—rheumatoid arthritis	0.000138	0.000483	CcSEcCtD
Nefazodone—Anorexia—Betamethasone—rheumatoid arthritis	0.000138	0.000482	CcSEcCtD
Nefazodone—Anorexia—Dexamethasone—rheumatoid arthritis	0.000138	0.000482	CcSEcCtD
Nefazodone—Urticaria—Prednisolone—rheumatoid arthritis	0.000137	0.000482	CcSEcCtD
Nefazodone—Asthenia—Cyclosporine—rheumatoid arthritis	0.000136	0.000478	CcSEcCtD
Nefazodone—Pain—Triamcinolone—rheumatoid arthritis	0.000136	0.000477	CcSEcCtD
Nefazodone—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000135	0.000475	CcSEcCtD
Nefazodone—Hypotension—Dexamethasone—rheumatoid arthritis	0.000135	0.000473	CcSEcCtD
Nefazodone—Hypotension—Betamethasone—rheumatoid arthritis	0.000135	0.000473	CcSEcCtD
Nefazodone—Pruritus—Cyclosporine—rheumatoid arthritis	0.000135	0.000472	CcSEcCtD
Nefazodone—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000134	0.000471	CcSEcCtD
Nefazodone—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000134	0.000468	CcSEcCtD
Nefazodone—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000134	0.000468	CcSEcCtD
Nefazodone—Convulsion—Prednisone—rheumatoid arthritis	0.000133	0.000468	CcSEcCtD
Nefazodone—Hypertension—Prednisone—rheumatoid arthritis	0.000133	0.000466	CcSEcCtD
Nefazodone—Chills—Methotrexate—rheumatoid arthritis	0.000133	0.000465	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000132	0.000461	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000132	0.000461	CcSEcCtD
Nefazodone—Arthralgia—Prednisone—rheumatoid arthritis	0.000131	0.00046	CcSEcCtD
Nefazodone—Myalgia—Prednisone—rheumatoid arthritis	0.000131	0.00046	CcSEcCtD
Nefazodone—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000131	0.00046	CcSEcCtD
Nefazodone—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000131	0.000459	CcSEcCtD
Nefazodone—Anxiety—Prednisone—rheumatoid arthritis	0.000131	0.000458	CcSEcCtD
Nefazodone—Alopecia—Methotrexate—rheumatoid arthritis	0.000131	0.000458	CcSEcCtD
Nefazodone—Insomnia—Dexamethasone—rheumatoid arthritis	0.000131	0.000458	CcSEcCtD
Nefazodone—Insomnia—Betamethasone—rheumatoid arthritis	0.000131	0.000458	CcSEcCtD
Nefazodone—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.00013	0.000456	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.00013	0.000455	CcSEcCtD
Nefazodone—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.00013	0.000454	CcSEcCtD
Nefazodone—Paraesthesia—Betamethasone—rheumatoid arthritis	0.00013	0.000454	CcSEcCtD
Nefazodone—Discomfort—Prednisone—rheumatoid arthritis	0.00013	0.000454	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000127	0.000447	CcSEcCtD
Nefazodone—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000127	0.000446	CcSEcCtD
Nefazodone—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000127	0.000446	CcSEcCtD
Nefazodone—Urticaria—Triamcinolone—rheumatoid arthritis	0.000126	0.000443	CcSEcCtD
Nefazodone—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000126	0.000442	CcSEcCtD
Nefazodone—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000126	0.000442	CcSEcCtD
Nefazodone—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000126	0.000441	CcSEcCtD
Nefazodone—Dizziness—Cyclosporine—rheumatoid arthritis	0.000126	0.000441	CcSEcCtD
Nefazodone—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000126	0.000441	CcSEcCtD
Nefazodone—Oedema—Prednisone—rheumatoid arthritis	0.000126	0.000441	CcSEcCtD
Nefazodone—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000125	0.00044	CcSEcCtD
Nefazodone—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000125	0.00044	CcSEcCtD
Nefazodone—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000125	0.00044	CcSEcCtD
Nefazodone—Infection—Prednisone—rheumatoid arthritis	0.000125	0.000438	CcSEcCtD
Nefazodone—Back pain—Methotrexate—rheumatoid arthritis	0.000125	0.000437	CcSEcCtD
Nefazodone—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000124	0.000436	CcSEcCtD
Nefazodone—Shock—Prednisone—rheumatoid arthritis	0.000124	0.000434	CcSEcCtD
Nefazodone—Pain—Betamethasone—rheumatoid arthritis	0.000123	0.000433	CcSEcCtD
Nefazodone—Pain—Dexamethasone—rheumatoid arthritis	0.000123	0.000433	CcSEcCtD
Nefazodone—Tachycardia—Prednisone—rheumatoid arthritis	0.000123	0.00043	CcSEcCtD
Nefazodone—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000122	0.000426	CcSEcCtD
Nefazodone—Vision blurred—Methotrexate—rheumatoid arthritis	0.000121	0.000425	CcSEcCtD
Nefazodone—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000121	0.000425	CcSEcCtD
Nefazodone—Vomiting—Cyclosporine—rheumatoid arthritis	0.000121	0.000424	CcSEcCtD
Nefazodone—Rash—Cyclosporine—rheumatoid arthritis	0.00012	0.00042	CcSEcCtD
Nefazodone—Anorexia—Prednisone—rheumatoid arthritis	0.00012	0.00042	CcSEcCtD
Nefazodone—Dermatitis—Cyclosporine—rheumatoid arthritis	0.00012	0.00042	CcSEcCtD
Nefazodone—Pruritus—Hydrocortisone—rheumatoid arthritis	0.00012	0.000419	CcSEcCtD
Nefazodone—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000119	0.000419	CcSEcCtD
Nefazodone—Headache—Cyclosporine—rheumatoid arthritis	0.000119	0.000418	CcSEcCtD
Nefazodone—Anaemia—Methotrexate—rheumatoid arthritis	0.000119	0.000417	CcSEcCtD
Nefazodone—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000119	0.000417	CcSEcCtD
Nefazodone—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000119	0.000417	CcSEcCtD
Nefazodone—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000118	0.000414	CcSEcCtD
Nefazodone—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000118	0.000414	CcSEcCtD
Nefazodone—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000117	0.000411	CcSEcCtD
Nefazodone—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000117	0.00041	CcSEcCtD
Nefazodone—Malaise—Methotrexate—rheumatoid arthritis	0.000116	0.000407	CcSEcCtD
Nefazodone—Vertigo—Methotrexate—rheumatoid arthritis	0.000116	0.000405	CcSEcCtD
Nefazodone—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000116	0.000405	CcSEcCtD
Nefazodone—Leukopenia—Methotrexate—rheumatoid arthritis	0.000115	0.000404	CcSEcCtD
Nefazodone—Urticaria—Dexamethasone—rheumatoid arthritis	0.000115	0.000402	CcSEcCtD
Nefazodone—Urticaria—Betamethasone—rheumatoid arthritis	0.000115	0.000402	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000115	0.000402	CcSEcCtD
Nefazodone—Dizziness—Prednisolone—rheumatoid arthritis	0.000114	0.000401	CcSEcCtD
Nefazodone—Asthenia—Triamcinolone—rheumatoid arthritis	0.000114	0.0004	CcSEcCtD
Nefazodone—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000114	0.0004	CcSEcCtD
Nefazodone—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000114	0.0004	CcSEcCtD
Nefazodone—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000114	0.0004	CcSEcCtD
Nefazodone—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000114	0.0004	CcSEcCtD
Nefazodone—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000114	0.000399	CcSEcCtD
Nefazodone—Insomnia—Prednisone—rheumatoid arthritis	0.000114	0.000399	CcSEcCtD
Nefazodone—Nausea—Cyclosporine—rheumatoid arthritis	0.000113	0.000396	CcSEcCtD
Nefazodone—Paraesthesia—Prednisone—rheumatoid arthritis	0.000113	0.000396	CcSEcCtD
Nefazodone—Pruritus—Triamcinolone—rheumatoid arthritis	0.000113	0.000395	CcSEcCtD
Nefazodone—Cough—Methotrexate—rheumatoid arthritis	0.000112	0.000394	CcSEcCtD
Nefazodone—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000112	0.000394	CcSEcCtD
Nefazodone—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000112	0.000392	CcSEcCtD
Nefazodone—Convulsion—Methotrexate—rheumatoid arthritis	0.000112	0.000391	CcSEcCtD
Nefazodone—Dyspepsia—Prednisone—rheumatoid arthritis	0.000111	0.000388	CcSEcCtD
Nefazodone—Arthralgia—Methotrexate—rheumatoid arthritis	0.00011	0.000384	CcSEcCtD
Nefazodone—Chest pain—Methotrexate—rheumatoid arthritis	0.00011	0.000384	CcSEcCtD
Nefazodone—Myalgia—Methotrexate—rheumatoid arthritis	0.00011	0.000384	CcSEcCtD
Nefazodone—Decreased appetite—Prednisone—rheumatoid arthritis	0.000109	0.000383	CcSEcCtD
Nefazodone—Rash—Prednisolone—rheumatoid arthritis	0.000109	0.000382	CcSEcCtD
Nefazodone—Dermatitis—Prednisolone—rheumatoid arthritis	0.000109	0.000382	CcSEcCtD
Nefazodone—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000109	0.000381	CcSEcCtD
Nefazodone—Headache—Prednisolone—rheumatoid arthritis	0.000108	0.00038	CcSEcCtD
Nefazodone—Discomfort—Methotrexate—rheumatoid arthritis	0.000108	0.00038	CcSEcCtD
Nefazodone—Constipation—Prednisone—rheumatoid arthritis	0.000108	0.000377	CcSEcCtD
Nefazodone—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000107	0.000377	CcSEcCtD
Nefazodone—Rash—Hydrocortisone—rheumatoid arthritis	0.000107	0.000374	CcSEcCtD
Nefazodone—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000106	0.000373	CcSEcCtD
Nefazodone—Confusional state—Methotrexate—rheumatoid arthritis	0.000106	0.000371	CcSEcCtD
Nefazodone—Headache—Hydrocortisone—rheumatoid arthritis	0.000106	0.000371	CcSEcCtD
Nefazodone—Dizziness—Triamcinolone—rheumatoid arthritis	0.000105	0.000369	CcSEcCtD
Nefazodone—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000105	0.000368	CcSEcCtD
Nefazodone—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000105	0.000368	CcSEcCtD
Nefazodone—Infection—Methotrexate—rheumatoid arthritis	0.000104	0.000366	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000104	0.000363	CcSEcCtD
Nefazodone—Asthenia—Dexamethasone—rheumatoid arthritis	0.000104	0.000363	CcSEcCtD
Nefazodone—Asthenia—Betamethasone—rheumatoid arthritis	0.000104	0.000363	CcSEcCtD
Nefazodone—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000103	0.000361	CcSEcCtD
Nefazodone—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000103	0.00036	CcSEcCtD
Nefazodone—Nausea—Prednisolone—rheumatoid arthritis	0.000103	0.00036	CcSEcCtD
Nefazodone—Pruritus—Dexamethasone—rheumatoid arthritis	0.000102	0.000358	CcSEcCtD
Nefazodone—Pruritus—Betamethasone—rheumatoid arthritis	0.000102	0.000358	CcSEcCtD
Nefazodone—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000102	0.000356	CcSEcCtD
Nefazodone—Vomiting—Triamcinolone—rheumatoid arthritis	0.000101	0.000355	CcSEcCtD
Nefazodone—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000101	0.000354	CcSEcCtD
Nefazodone—Nausea—Hydrocortisone—rheumatoid arthritis	0.0001	0.000352	CcSEcCtD
Nefazodone—Rash—Triamcinolone—rheumatoid arthritis	0.0001	0.000352	CcSEcCtD
Nefazodone—Dermatitis—Triamcinolone—rheumatoid arthritis	0.0001	0.000351	CcSEcCtD
Nefazodone—Anorexia—Methotrexate—rheumatoid arthritis	0.0001	0.000351	CcSEcCtD
Nefazodone—Rash—Methylprednisolone—rheumatoid arthritis	0.0001	0.000351	CcSEcCtD
Nefazodone—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.0001	0.000351	CcSEcCtD
Nefazodone—Urticaria—Prednisone—rheumatoid arthritis	9.99e-05	0.00035	CcSEcCtD
Nefazodone—Headache—Triamcinolone—rheumatoid arthritis	9.97e-05	0.000349	CcSEcCtD
Nefazodone—Headache—Methylprednisolone—rheumatoid arthritis	9.95e-05	0.000349	CcSEcCtD
Nefazodone—Abdominal pain—Prednisone—rheumatoid arthritis	9.94e-05	0.000348	CcSEcCtD
Nefazodone—Body temperature increased—Prednisone—rheumatoid arthritis	9.94e-05	0.000348	CcSEcCtD
Nefazodone—Diarrhoea—Betamethasone—rheumatoid arthritis	9.88e-05	0.000346	CcSEcCtD
Nefazodone—Diarrhoea—Dexamethasone—rheumatoid arthritis	9.88e-05	0.000346	CcSEcCtD
Nefazodone—Hypotension—Methotrexate—rheumatoid arthritis	9.82e-05	0.000344	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	9.57e-05	0.000336	CcSEcCtD
Nefazodone—Dizziness—Betamethasone—rheumatoid arthritis	9.55e-05	0.000335	CcSEcCtD
Nefazodone—Dizziness—Dexamethasone—rheumatoid arthritis	9.55e-05	0.000335	CcSEcCtD
Nefazodone—Insomnia—Methotrexate—rheumatoid arthritis	9.5e-05	0.000333	CcSEcCtD
Nefazodone—Nausea—Triamcinolone—rheumatoid arthritis	9.45e-05	0.000331	CcSEcCtD
Nefazodone—Paraesthesia—Methotrexate—rheumatoid arthritis	9.43e-05	0.000331	CcSEcCtD
Nefazodone—Nausea—Methylprednisolone—rheumatoid arthritis	9.43e-05	0.000331	CcSEcCtD
Nefazodone—Dyspnoea—Methotrexate—rheumatoid arthritis	9.37e-05	0.000328	CcSEcCtD
Nefazodone—Somnolence—Methotrexate—rheumatoid arthritis	9.34e-05	0.000327	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisone—rheumatoid arthritis	9.26e-05	0.000325	CcSEcCtD
Nefazodone—Dyspepsia—Methotrexate—rheumatoid arthritis	9.25e-05	0.000324	CcSEcCtD
Nefazodone—Vomiting—Betamethasone—rheumatoid arthritis	9.18e-05	0.000322	CcSEcCtD
Nefazodone—Vomiting—Dexamethasone—rheumatoid arthritis	9.18e-05	0.000322	CcSEcCtD
Nefazodone—Decreased appetite—Methotrexate—rheumatoid arthritis	9.13e-05	0.00032	CcSEcCtD
Nefazodone—Rash—Betamethasone—rheumatoid arthritis	9.1e-05	0.000319	CcSEcCtD
Nefazodone—Rash—Dexamethasone—rheumatoid arthritis	9.1e-05	0.000319	CcSEcCtD
Nefazodone—Dermatitis—Betamethasone—rheumatoid arthritis	9.09e-05	0.000319	CcSEcCtD
Nefazodone—Dermatitis—Dexamethasone—rheumatoid arthritis	9.09e-05	0.000319	CcSEcCtD
Nefazodone—Headache—Betamethasone—rheumatoid arthritis	9.04e-05	0.000317	CcSEcCtD
Nefazodone—Headache—Dexamethasone—rheumatoid arthritis	9.04e-05	0.000317	CcSEcCtD
Nefazodone—Asthenia—Prednisone—rheumatoid arthritis	9.02e-05	0.000316	CcSEcCtD
Nefazodone—Pain—Methotrexate—rheumatoid arthritis	8.98e-05	0.000315	CcSEcCtD
Nefazodone—Pruritus—Prednisone—rheumatoid arthritis	8.89e-05	0.000312	CcSEcCtD
Nefazodone—Feeling abnormal—Methotrexate—rheumatoid arthritis	8.66e-05	0.000304	CcSEcCtD
Nefazodone—Diarrhoea—Prednisone—rheumatoid arthritis	8.6e-05	0.000302	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	8.59e-05	0.000301	CcSEcCtD
Nefazodone—Nausea—Betamethasone—rheumatoid arthritis	8.57e-05	0.000301	CcSEcCtD
Nefazodone—Nausea—Dexamethasone—rheumatoid arthritis	8.57e-05	0.000301	CcSEcCtD
Nefazodone—Urticaria—Methotrexate—rheumatoid arthritis	8.35e-05	0.000293	CcSEcCtD
Nefazodone—Dizziness—Prednisone—rheumatoid arthritis	8.31e-05	0.000291	CcSEcCtD
Nefazodone—Body temperature increased—Methotrexate—rheumatoid arthritis	8.31e-05	0.000291	CcSEcCtD
Nefazodone—Abdominal pain—Methotrexate—rheumatoid arthritis	8.31e-05	0.000291	CcSEcCtD
Nefazodone—Vomiting—Prednisone—rheumatoid arthritis	7.99e-05	0.00028	CcSEcCtD
Nefazodone—Rash—Prednisone—rheumatoid arthritis	7.93e-05	0.000278	CcSEcCtD
Nefazodone—Dermatitis—Prednisone—rheumatoid arthritis	7.92e-05	0.000278	CcSEcCtD
Nefazodone—Headache—Prednisone—rheumatoid arthritis	7.88e-05	0.000276	CcSEcCtD
Nefazodone—Hypersensitivity—Methotrexate—rheumatoid arthritis	7.74e-05	0.000271	CcSEcCtD
Nefazodone—Asthenia—Methotrexate—rheumatoid arthritis	7.54e-05	0.000264	CcSEcCtD
Nefazodone—Nausea—Prednisone—rheumatoid arthritis	7.47e-05	0.000262	CcSEcCtD
Nefazodone—Pruritus—Methotrexate—rheumatoid arthritis	7.43e-05	0.000261	CcSEcCtD
Nefazodone—Diarrhoea—Methotrexate—rheumatoid arthritis	7.19e-05	0.000252	CcSEcCtD
Nefazodone—Dizziness—Methotrexate—rheumatoid arthritis	6.95e-05	0.000244	CcSEcCtD
Nefazodone—Vomiting—Methotrexate—rheumatoid arthritis	6.68e-05	0.000234	CcSEcCtD
Nefazodone—Rash—Methotrexate—rheumatoid arthritis	6.62e-05	0.000232	CcSEcCtD
Nefazodone—Dermatitis—Methotrexate—rheumatoid arthritis	6.62e-05	0.000232	CcSEcCtD
Nefazodone—Headache—Methotrexate—rheumatoid arthritis	6.58e-05	0.000231	CcSEcCtD
Nefazodone—Nausea—Methotrexate—rheumatoid arthritis	6.24e-05	0.000219	CcSEcCtD
Nefazodone—HTR2A—Signaling Pathways—STAT1—rheumatoid arthritis	9.67e-06	0.000181	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	9.64e-06	0.000181	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PRKCQ—rheumatoid arthritis	9.64e-06	0.00018	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PTK2—rheumatoid arthritis	9.64e-06	0.00018	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—CXCL8—rheumatoid arthritis	9.59e-06	0.00018	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MMP3—rheumatoid arthritis	9.58e-06	0.000179	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—TYK2—rheumatoid arthritis	9.58e-06	0.000179	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—POMC—rheumatoid arthritis	9.58e-06	0.000179	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CCL2—rheumatoid arthritis	9.57e-06	0.000179	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6R—rheumatoid arthritis	9.54e-06	0.000179	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCL10—rheumatoid arthritis	9.53e-06	0.000178	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL5—rheumatoid arthritis	9.5e-06	0.000178	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—STAT1—rheumatoid arthritis	9.47e-06	0.000177	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL5—rheumatoid arthritis	9.45e-06	0.000177	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CAT—rheumatoid arthritis	9.42e-06	0.000176	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CCL2—rheumatoid arthritis	9.37e-06	0.000175	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CSF2—rheumatoid arthritis	9.36e-06	0.000175	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6R—rheumatoid arthritis	9.34e-06	0.000175	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCL10—rheumatoid arthritis	9.33e-06	0.000175	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CSF2—rheumatoid arthritis	9.31e-06	0.000174	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PTK2—rheumatoid arthritis	9.23e-06	0.000173	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—IL2—rheumatoid arthritis	9.22e-06	0.000173	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—CXCL8—rheumatoid arthritis	9.18e-06	0.000172	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—IL2—rheumatoid arthritis	9.17e-06	0.000172	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RASGRP1—rheumatoid arthritis	9.15e-06	0.000171	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SYK—rheumatoid arthritis	9.12e-06	0.000171	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ENO1—rheumatoid arthritis	9.05e-06	0.000169	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL5—rheumatoid arthritis	9.05e-06	0.000169	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PRKCQ—rheumatoid arthritis	8.95e-06	0.000168	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TGFB1—rheumatoid arthritis	8.94e-06	0.000167	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CSF2—rheumatoid arthritis	8.91e-06	0.000167	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—POMC—rheumatoid arthritis	8.9e-06	0.000167	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MED1—rheumatoid arthritis	8.88e-06	0.000166	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—STAT1—rheumatoid arthritis	8.8e-06	0.000165	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SPP1—rheumatoid arthritis	8.8e-06	0.000165	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—IL2—rheumatoid arthritis	8.78e-06	0.000164	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CXCL8—rheumatoid arthritis	8.76e-06	0.000164	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SPP1—rheumatoid arthritis	8.75e-06	0.000164	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CXCL8—rheumatoid arthritis	8.71e-06	0.000163	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCL2—rheumatoid arthritis	8.71e-06	0.000163	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MMP3—rheumatoid arthritis	8.69e-06	0.000163	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—TYK2—rheumatoid arthritis	8.69e-06	0.000163	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6R—rheumatoid arthritis	8.68e-06	0.000162	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCL10—rheumatoid arthritis	8.67e-06	0.000162	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CAT—rheumatoid arthritis	8.63e-06	0.000162	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCR5—rheumatoid arthritis	8.56e-06	0.00016	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	8.53e-06	0.00016	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MMP3—rheumatoid arthritis	8.51e-06	0.000159	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCR5—rheumatoid arthritis	8.51e-06	0.000159	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—TYK2—rheumatoid arthritis	8.51e-06	0.000159	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	8.46e-06	0.000158	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2RA—rheumatoid arthritis	8.43e-06	0.000158	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2RA—rheumatoid arthritis	8.39e-06	0.000157	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SPP1—rheumatoid arthritis	8.38e-06	0.000157	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL2—rheumatoid arthritis	8.37e-06	0.000157	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PTK2—rheumatoid arthritis	8.37e-06	0.000157	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—C3—rheumatoid arthritis	8.36e-06	0.000157	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CXCL8—rheumatoid arthritis	8.34e-06	0.000156	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	8.33e-06	0.000156	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL2—rheumatoid arthritis	8.33e-06	0.000156	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—C3—rheumatoid arthritis	8.32e-06	0.000156	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	8.25e-06	0.000154	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	8.25e-06	0.000154	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL5—rheumatoid arthritis	8.21e-06	0.000154	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PTK2—rheumatoid arthritis	8.19e-06	0.000153	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	8.16e-06	0.000153	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCR5—rheumatoid arthritis	8.15e-06	0.000153	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CSF2—rheumatoid arthritis	8.08e-06	0.000151	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL5—rheumatoid arthritis	8.04e-06	0.00015	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2RA—rheumatoid arthritis	8.03e-06	0.00015	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL2—rheumatoid arthritis	7.97e-06	0.000149	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—POMC—rheumatoid arthritis	7.97e-06	0.000149	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—C3—rheumatoid arthritis	7.96e-06	0.000149	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL2—rheumatoid arthritis	7.96e-06	0.000149	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CSF2—rheumatoid arthritis	7.91e-06	0.000148	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MMP3—rheumatoid arthritis	7.91e-06	0.000148	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—TYK2—rheumatoid arthritis	7.91e-06	0.000148	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—MTHFR—rheumatoid arthritis	7.86e-06	0.000147	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL2—rheumatoid arthritis	7.8e-06	0.000146	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—LEP—rheumatoid arthritis	7.79e-06	0.000146	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—LEP—rheumatoid arthritis	7.75e-06	0.000145	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PTK2—rheumatoid arthritis	7.61e-06	0.000143	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SPP1—rheumatoid arthritis	7.6e-06	0.000142	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	7.58e-06	0.000142	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.57e-06	0.000142	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL5—rheumatoid arthritis	7.47e-06	0.00014	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SPP1—rheumatoid arthritis	7.44e-06	0.000139	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—BGN—rheumatoid arthritis	7.43e-06	0.000139	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—LEP—rheumatoid arthritis	7.41e-06	0.000139	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.41e-06	0.000139	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCR5—rheumatoid arthritis	7.39e-06	0.000138	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TP53—rheumatoid arthritis	7.36e-06	0.000138	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CSF2—rheumatoid arthritis	7.35e-06	0.000138	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—FN1—rheumatoid arthritis	7.34e-06	0.000137	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6ST—rheumatoid arthritis	7.31e-06	0.000137	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—FN1—rheumatoid arthritis	7.3e-06	0.000137	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2RA—rheumatoid arthritis	7.29e-06	0.000136	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6ST—rheumatoid arthritis	7.27e-06	0.000136	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ALB—rheumatoid arthritis	7.27e-06	0.000136	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL2—rheumatoid arthritis	7.24e-06	0.000136	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCR5—rheumatoid arthritis	7.24e-06	0.000135	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL2—rheumatoid arthritis	7.23e-06	0.000135	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—C3—rheumatoid arthritis	7.22e-06	0.000135	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	7.2e-06	0.000135	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2RA—rheumatoid arthritis	7.13e-06	0.000134	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL2—rheumatoid arthritis	7.08e-06	0.000133	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—C3—rheumatoid arthritis	7.07e-06	0.000132	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CD80—rheumatoid arthritis	7.04e-06	0.000132	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CD80—rheumatoid arthritis	7e-06	0.000131	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—FN1—rheumatoid arthritis	6.99e-06	0.000131	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6ST—rheumatoid arthritis	6.96e-06	0.00013	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—NOS3—rheumatoid arthritis	6.95e-06	0.00013	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SPP1—rheumatoid arthritis	6.91e-06	0.000129	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	6.88e-06	0.000129	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	6.84e-06	0.000128	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCR5—rheumatoid arthritis	6.73e-06	0.000126	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—LEP—rheumatoid arthritis	6.73e-06	0.000126	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CD80—rheumatoid arthritis	6.7e-06	0.000125	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—POMC—rheumatoid arthritis	6.69e-06	0.000125	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—POMC—rheumatoid arthritis	6.65e-06	0.000125	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	6.63e-06	0.000124	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—LEP—rheumatoid arthritis	6.59e-06	0.000123	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL2—rheumatoid arthritis	6.58e-06	0.000123	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—C3—rheumatoid arthritis	6.57e-06	0.000123	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL2—rheumatoid arthritis	6.54e-06	0.000122	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6R—rheumatoid arthritis	6.52e-06	0.000122	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CAT—rheumatoid arthritis	6.51e-06	0.000122	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL2—rheumatoid arthritis	6.51e-06	0.000122	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6R—rheumatoid arthritis	6.49e-06	0.000121	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—POMC—rheumatoid arthritis	6.37e-06	0.000119	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTGS2—rheumatoid arthritis	6.36e-06	0.000119	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—FN1—rheumatoid arthritis	6.34e-06	0.000119	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6ST—rheumatoid arthritis	6.32e-06	0.000118	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—POMC—rheumatoid arthritis	6.29e-06	0.000118	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL2—rheumatoid arthritis	6.23e-06	0.000117	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6R—rheumatoid arthritis	6.21e-06	0.000116	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—FN1—rheumatoid arthritis	6.21e-06	0.000116	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6ST—rheumatoid arthritis	6.19e-06	0.000116	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CAT—rheumatoid arthritis	6.14e-06	0.000115	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—LEP—rheumatoid arthritis	6.12e-06	0.000115	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CD80—rheumatoid arthritis	6.08e-06	0.000114	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CD80—rheumatoid arthritis	5.95e-06	0.000111	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TYK2—rheumatoid arthritis	5.94e-06	0.000111	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TYK2—rheumatoid arthritis	5.91e-06	0.000111	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NOS3—rheumatoid arthritis	5.83e-06	0.000109	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NOS3—rheumatoid arthritis	5.8e-06	0.000109	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	5.78e-06	0.000108	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	5.77e-06	0.000108	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—POMC—rheumatoid arthritis	5.76e-06	0.000108	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	5.75e-06	0.000108	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALB—rheumatoid arthritis	5.73e-06	0.000107	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TYK2—rheumatoid arthritis	5.66e-06	0.000106	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—POMC—rheumatoid arthritis	5.66e-06	0.000106	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	5.65e-06	0.000106	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	5.64e-06	0.000105	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	5.57e-06	0.000104	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NOS3—rheumatoid arthritis	5.55e-06	0.000104	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL2—rheumatoid arthritis	5.54e-06	0.000104	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	5.53e-06	0.000104	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6R—rheumatoid arthritis	5.52e-06	0.000103	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	5.48e-06	0.000103	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	5.44e-06	0.000102	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	5.26e-06	9.84e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALB—rheumatoid arthritis	5.25e-06	9.83e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CXCL8—rheumatoid arthritis	5.17e-06	9.68e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CXCL8—rheumatoid arthritis	5.15e-06	9.63e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	5.14e-06	9.63e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	5.13e-06	9.61e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	5.13e-06	9.6e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	5.12e-06	9.59e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	5.04e-06	9.43e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TYK2—rheumatoid arthritis	5.03e-06	9.41e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	5.02e-06	9.4e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	5.01e-06	9.38e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2—rheumatoid arthritis	4.94e-06	9.25e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NOS3—rheumatoid arthritis	4.93e-06	9.23e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CXCL8—rheumatoid arthritis	4.93e-06	9.22e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—rheumatoid arthritis	4.92e-06	9.21e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2—rheumatoid arthritis	4.92e-06	9.21e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—rheumatoid arthritis	4.89e-06	9.16e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2—rheumatoid arthritis	4.71e-06	8.81e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—rheumatoid arthritis	4.69e-06	8.77e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MMP9—rheumatoid arthritis	4.68e-06	8.76e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	4.67e-06	8.74e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MMP9—rheumatoid arthritis	4.66e-06	8.71e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NFKB1—rheumatoid arthritis	4.63e-06	8.67e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NFKB1—rheumatoid arthritis	4.61e-06	8.62e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	4.59e-06	8.6e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	4.58e-06	8.58e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MAPK8—rheumatoid arthritis	4.55e-06	8.52e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MAPK8—rheumatoid arthritis	4.53e-06	8.47e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	4.47e-06	8.37e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MMP9—rheumatoid arthritis	4.46e-06	8.34e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NFKB1—rheumatoid arthritis	4.41e-06	8.25e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCL8—rheumatoid arthritis	4.38e-06	8.19e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—POMC—rheumatoid arthritis	4.35e-06	8.14e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MAPK8—rheumatoid arthritis	4.33e-06	8.11e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	4.27e-06	7.99e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	4.25e-06	7.95e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—VEGFA—rheumatoid arthritis	4.2e-06	7.86e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2—rheumatoid arthritis	4.18e-06	7.83e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—VEGFA—rheumatoid arthritis	4.18e-06	7.82e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—rheumatoid arthritis	4.16e-06	7.79e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—POMC—rheumatoid arthritis	4.1e-06	7.67e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	4.07e-06	7.61e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	4.04e-06	7.57e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CAT—rheumatoid arthritis	4.01e-06	7.51e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—VEGFA—rheumatoid arthritis	4e-06	7.49e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	4e-06	7.49e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALB—rheumatoid arthritis	3.96e-06	7.42e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MMP9—rheumatoid arthritis	3.96e-06	7.41e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.93e-06	7.36e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.92e-06	7.33e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	3.89e-06	7.27e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	3.87e-06	7.24e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TGFB1—rheumatoid arthritis	3.86e-06	7.22e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.85e-06	7.21e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TGFB1—rheumatoid arthritis	3.84e-06	7.18e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NOS3—rheumatoid arthritis	3.79e-06	7.1e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALB—rheumatoid arthritis	3.73e-06	6.99e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	3.68e-06	6.88e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TGFB1—rheumatoid arthritis	3.67e-06	6.87e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.64e-06	6.81e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.63e-06	6.79e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.58e-06	6.69e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	3.57e-06	6.69e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.55e-06	6.65e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	3.47e-06	6.49e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	3.35e-06	6.27e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	3.33e-06	6.24e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.3e-06	6.18e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	3.27e-06	6.12e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TGFB1—rheumatoid arthritis	3.26e-06	6.11e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TP53—rheumatoid arthritis	3.18e-06	5.94e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TP53—rheumatoid arthritis	3.16e-06	5.91e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	3.03e-06	5.67e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TP53—rheumatoid arthritis	3.02e-06	5.66e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—rheumatoid arthritis	2.91e-06	5.44e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—rheumatoid arthritis	2.89e-06	5.41e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—rheumatoid arthritis	2.77e-06	5.18e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	2.74e-06	5.13e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TP53—rheumatoid arthritis	2.69e-06	5.03e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—POMC—rheumatoid arthritis	2.68e-06	5.01e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	2.51e-06	4.7e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	2.5e-06	4.67e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—rheumatoid arthritis	2.46e-06	4.6e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALB—rheumatoid arthritis	2.44e-06	4.57e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	2.34e-06	4.37e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	2.28e-06	4.28e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	2.14e-06	4e-05	CbGpPWpGaD
